ALNYLAM PHARMACEUTICALS, INC. Free Cash Flow 2008-2025 | ALNY
Beta
What is ALNYLAM PHARMACEUTICALS, INC.'s current free cash flow?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual free cash flow for 2025 was $465.4M, a 1192.73% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. free cash flow for the quarter ending December 31, 2025 was $140.3M.
What was ALNYLAM PHARMACEUTICALS, INC.'s free cash flow in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual free cash flow for 2024 was $-42.6M, a 201.54% decline from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s free cash flow in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual free cash flow for 2023 was $41.9M, a 106.84% increase from 2022.
Free Cash Flow History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGRN/A
FY2020
$-685.3M
→
FY2025
$465.4M
080910111213141516171819202122232425
5 years selected
Free Cash Flow History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $465.4M | +1192.7% | 10-K |
| FY2024 | $-42.6M | -201.5% | 10-K |
| FY2023 | $41.9M | +106.8% | 10-K |
| FY2022 | $-613.3M | +14.6% | 10-K |
| FY2021 | $-718.1M | -4.8% | 10-K |
| FY2020 | $-685.3M | -63.7% | 10-K |
| FY2019 | $-418.6M | +39.3% | 10-K |
| FY2018 | $-689.5M | -41.6% | 10-K |
| FY2017 | $-487.0M | -30.8% | 10-K |
| FY2016 | $-372.3M | -84.2% | 10-K |
| FY2015 | $-202.1M | -15.7% | 10-K |
| FY2014 | $-174.6M | -140.3% | 10-K |
| FY2013 | $-72.7M | +41.4% | 10-K |
| FY2012 | $-124.0M | -40.3% | 10-K |
| FY2011 | $-88.4M | +0.8% | 10-K |
| FY2010 | $-89.1M | -15.5% | 10-K |
| FY2009 | $-77.1M | -240.9% | 10-K |
| FY2008 | $54.7M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →